CORD-19:c654596857bce9cdd64ffc51842048643107348c / 194597-194691 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/c654596857bce9cdd64ffc51842048643107348c","sourcedb":"CORD-19","sourceid":"c654596857bce9cdd64ffc51842048643107348c","text":"Anti-HGV antibodies were detected in the control group (blood donors) in 8.3% (2/24) patients.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1622","span":{"begin":0,"end":94},"obj":"Sentence"},{"id":"T86745","span":{"begin":0,"end":94},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T1622","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T86745","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T369","span":{"begin":0,"end":94},"obj":"Sentence"}],"attributes":[{"subj":"T369","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T182","span":{"begin":56,"end":61},"obj":"Body_part"}],"attributes":[{"id":"A182","pred":"uberon_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"subj":"T182","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#a1ec93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec93bb"},{"id":"CORD-19-PD-UBERON","color":"#93d5ec"}]}]}}